heapsreal
iherb 10% discount code OPA989,
- Messages
- 10,212
- Location
- australia (brisbane)
Thought this might be of interest
http://www.inotekcorp.com/publications/pdf/ipcpub306.pdf
Adenosine has been considered as a potential immunomodulatory
and neuroprotective agent for 30 years.
Inosine, a major degradation product of adenosine,
was thought originally to have no biological effects.
However, recent studies demonstrate that inosine has
potent immunomodulatory and neuroprotective effects.
Inosine enhances mast-cell degranulation, attenuates
the production of pro-inflammatory mediators by
macrophages, lymphocytes and neutrophils, and is protective
in animal models of sepsis, ischemia–reperfusion
and autoimmunity. Inosine preserves the viability
of glial cells and neuronal cells during hypoxia, and
stimulates axonal regrowth after injury. The biological
actions of inosine might involve effects on adenosine
receptors, poly(ADP-ribose) polymerase and cellular
energy levels. In this article, we review recent observations
indicating that it might be possible to exploit
inosine therapeutically for the treatment of tissue
damage caused by inflammation and ischemia.
http://www.inotekcorp.com/publications/pdf/ipcpub306.pdf
Adenosine has been considered as a potential immunomodulatory
and neuroprotective agent for 30 years.
Inosine, a major degradation product of adenosine,
was thought originally to have no biological effects.
However, recent studies demonstrate that inosine has
potent immunomodulatory and neuroprotective effects.
Inosine enhances mast-cell degranulation, attenuates
the production of pro-inflammatory mediators by
macrophages, lymphocytes and neutrophils, and is protective
in animal models of sepsis, ischemia–reperfusion
and autoimmunity. Inosine preserves the viability
of glial cells and neuronal cells during hypoxia, and
stimulates axonal regrowth after injury. The biological
actions of inosine might involve effects on adenosine
receptors, poly(ADP-ribose) polymerase and cellular
energy levels. In this article, we review recent observations
indicating that it might be possible to exploit
inosine therapeutically for the treatment of tissue
damage caused by inflammation and ischemia.